VIDA Diagnostics, Inc. specializes in clinical imaging software and analysis services, focusing on lung and respiratory care. The company's flagship products include LungPrint, an automated AI-powered tool that analyzes chest CT scans to assess lung physiology and functional tissue, and VIDA|precision, which provides detailed lung measurements for pulmonary clinicians. Additionally, VIDA|vision enables interactive examination of advanced quantitative imaging analysis results. The company offers comprehensive image analysis services for both academic and clinical trials, including study design, CT protocol development, and data analysis. Founded in 2004 and headquartered in Coralville, Iowa, with an office in Minneapolis, VIDA's software is FDA cleared and CE-marked, making it suitable for clinical use in multiple regions, including the US, European Economic Area, Canada, and Australia. Through its innovative solutions, VIDA aims to empower healthcare organizations and physicians to enhance patient outcomes, especially for those at risk of chronic respiratory diseases such as COPD, interstitial lung disease, lung cancer, and COVID-19.